Related Experiment Videos

Serum 25-hydroxycalciferol in myocardial infarction

Atherosclerosis
|January 1, 1977
PubMed

Insights

Patients with myocardial infarction did not show higher vitamin D levels. This study measured 25-hydroxyvitamin D (25-OH-D) in patients and controls, finding seasonal variations and lower levels in older adults.

Area of Science:

  • Cardiology
  • Endocrinology
  • Nutritional Science

Background:

  • Vitamin D (calciferol) is crucial for overall health.
  • Previous observations suggested higher vitamin D intake in myocardial infarction (MI) patients.
  • The principal circulating form, 25-hydroxyvitamin D (25-OH-D), is a key biomarker.

Purpose of the Study:

  • To investigate serum 25-hydroxyvitamin D (25-OH-D) levels in patients with myocardial infarction (MI).
  • To compare 25-OH-D levels between MI patients and healthy controls.
  • To explore factors influencing 25-OH-D levels, such as season and age.

Main Methods:

  • Established an assay for quantifying 25-hydroxyvitamin D (25-OH-D).
  • Measured serum 25-OH-D concentrations in individuals with and without myocardial infarction.
  • Collected data on seasonal variations and age demographics of participants.

Main Results:

  • Control subjects exhibited seasonal variation in 25-OH-D, with higher levels in summer and lower levels in winter.
  • Older control subjects (above 60 years) had reduced 25-OH-D levels.
  • Myocardial infarction patients presented with both normal and low 25-OH-D values.

Conclusions:

  • The study concludes that patients with myocardial infarction in this region do not have a greater consumption of vitamin D.
  • Serum 25-OH-D levels are influenced by season and age in the general population.
  • Low 25-OH-D levels in MI patients were not consistently observed, challenging previous assumptions.

Related Concept Videos